Alzheimer's disease | |
---|---|
Other names | Alzheimer's dementia |
Diagram of a normal brain compared to the brain of a person with Alzheimer's | |
Pronunciation |
|
Specialty | Neurology |
Symptoms | Memory loss, problems with language, disorientation, mood swings[1][2] |
Complications | Infections, falls and aspiration pneumonia in the terminal stage[3] |
Usual onset | Over 65 years old[4] |
Duration | Long term[2] |
Causes | Poorly understood[1] |
Risk factors | Genetics, head injuries, clinical depression, hypertension,[1] psychological stress,[5] lack of physical[6] and mental[5][7] exercise |
Diagnostic method | Based on symptoms and cognitive testing after ruling out other possible causes[8] |
Differential diagnosis | Normal brain aging,[1] Lewy body dementia,[9] Trisomy 21[10] |
Medication | Acetylcholinesterase inhibitors, NMDA receptor antagonists[11] |
Prognosis | Life expectancy 3–12 years[11][12][13] |
Frequency | 50 million (2020)[14] |
Named after | Alois Alzheimer |
Alzheimer's disease | |
---|---|
Other names | Alzheimer's dementia |
Diagram of a normal brain compared to the brain of a person with Alzheimer's | |
Pronunciation |
|
Specialty | Neurology |
Symptoms | Memory loss, problems with language, disorientation, mood swings[1][2] |
Complications | Infections, falls and aspiration pneumonia in the terminal stage[3] |
Usual onset | Over 65 years old[4] |
Duration | Long term[2] |
Causes | Poorly understood[1] |
Risk factors | Genetics, head injuries, clinical depression, hypertension,[1] psychological stress,[5] lack of physical[6] and mental[5][7] exercise |
Diagnostic method | Based on symptoms and cognitive testing after ruling out other possible causes[8] |
Differential diagnosis | Normal brain aging,[1] Lewy body dementia,[9] Trisomy 21[10] |
Medication | Acetylcholinesterase inhibitors, NMDA receptor antagonists[11] |
Prognosis | Life expectancy 3–12 years[11][12][13] |
Frequency | 50 million (2020)[14] |
Named after | Alois Alzheimer |